TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT00718523

Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer

Cause of deathFunding or business Automatic label, confidence 0.5, unverified. How labels are made.
“The steering committee of the TRIO014 study has taken the decision to stop the TRIO014 trial.”

The sponsor’s own words in the registry.

Life of this trial

2008200920102011201220132014201520162017Registered2008-07-17Started2009-01Primary completion2013-09Stopped2014-11Results posted2016-01-12

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
Translational Research in Oncology
Sponsor type
University, hospital or other
Conditions
Ovarian Neoplasms
Interventions
AMG 479; AMG 479 Placebo
Participants
170
Sites
55
Countries
Canada, France, Germany, Ireland, Israel, Spain, United Kingdom, United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.